Spots Global Cancer Trial Database for VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: VTE Incidence After Curative Colon Cancer Surgery in an ERAS Program

Official Title: Incidence of Venous Thrombotic Event After Curative Colon Cancer Surgery in an Enhanced Recovery After Surgery Program

Study ID: NCT06009484

Conditions

Deep Vein Thrombosis, Pulmonary Embolus

Colon Cancer

Interventions

Colon resection

Study Description

Brief Summary: Based on data on a cohort of 2,141 patients undergoing elective colonic cancer resection in an ERAS program, the incidence of postoperative thromboembolic events is estimated in patients no receiving prolonged thromboembolic prophylaxis.

Detailed Description: The Copenhagen cOmplete Mesocolic Excision Study (COMES) database contains comprehensive data on preoperative, intraoperative, postoperative and tumor related variable on patients undergoing elective colonic cancer resection at four public university clinics providing all colorectal cancer treatment for the 1.8 million residents of the Capital Region of Denmark during the period 2014-2017. None of these hospitals had implemented prolonged thromboembolic prophylaxis after discharge. The medical records were reviewed with focusing on VTE prophylaxis, ongoing preoperative and postoperative anticoagulant treatment, the length of hospital stay (LOS), and readmission to ensure high data validity.